JDD March 2024 Issue Highlights
March into groundbreaking dermatological insights with the latest issue of the Journal of Drugs in Dermatology! Explore the prescribing habits of oral minoxidil for androgenetic alopecia, delve into a comprehensive review of botulinum toxin uses, and discover the effectiveness of microneedling for acne scars. Plus, unravel the uncertainties surrounding exosome therapy in androgenetic alopecia. Fro …
March into groundbreaking dermatological insights with the latest issue of the Journal of Drugs in Dermatology! Explore the prescribing habits of oral minoxidil for androgenetic alopecia, delve into a comprehensive review of botulinum toxin uses, and discover the effectiveness of microneedling for acne scars. Plus, unravel the uncertainties surrounding exosome therapy in androgenetic alopecia. Fro … 
At ODAC 2023, we had the opportunity to learn about cicatricial alopecias from renowned dermatologist and hair expert Dr. Amy McMichael, Professor of Dermatology at Wake Forest University School of Medicine.
First, we considered a framework to check for cicatricial alopecias. This is particularly important because if we can identify cicatricial alopecia, we can make sure we are treating the rig … 
A healthy 50-year-old patient presents with three-month history of progressive hair loss and scalp redness with associated pruritus. On closer scalp examination, there is perifollicular erythema, inflammation, and scaling. There appears to be loss of follicular openings in the erythematous patch. In addition, erythematous and skin-colored papules are present throughout the forehead. Of note, t … 
Trichoscopy is a handy dermoscopic tool that can be used at the bedside to diagnose multiple hair diseases. However, these hair diseases may be challenging to diagnose by the untrained eye. Fortunately, we had the opportunity to train these skills at ODAC 2023 with hair expert and dermatologist Dr. Amy McMichael, Professor of Dermatology at Wake Forest University. We will review the essentials of … 
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili … 